Inactive Instrument

Other languages Novo Nordisk A/S Xetra

Equities

End-of-day quote Xetra Other stock markets
- ^EUR	-

06/06	Novo Nordisk braces for Ozempic rivals in China	RE
06/06	European equities gain on tech boost in run-up to ECB	RE

Novo Nordisk bekommt in China Konkurrenz für Ozempic	06/06
Vers l'infini et au-delà	06/06
European equities gain on tech boost in run-up to ECB	06/06
Borsa di Italia: Verso l'infinito e oltre	06/06
IN DIRETTA DAI MERCATI: Diasorin, Finecobank, Unicredit, Generali, Stellantis, Poste Italiane, TIM, Novo Nordisk, Nvidia, Lululemon...	06/06
Bolsa de Madrid: Hasta el infinito y más allá	06/06
Novo Nordisk Faces Competition in China for Key Ingredient in Diabetes, Weight Loss Drug	06/06
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic	06/06
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China	06/06
UK Stocks-Factors to watch on June 6	05/06
UK Institute Makes Draft Recommendation for Eli Lilly's Weight-loss Drug With No Time Limit	05/06
Britain considers offering Lilly weight-loss drug on better terms than Wegovy	04/06
Adocia : un directeur des opérations nommé	04/06
Structure Therapeutics' obesity drug meets main goal in mid-stage study	03/06
JPMorgan European G&I raises dividend after outperforming benchmark	03/06
Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment	31/05
Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	30/05
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs	30/05
EARNINGS AND TRADING: First Tin "consolidates" holdings in Taronga	30/05
Catalent Shareholders Approve Deal With Novo Holdings	29/05